TECHNOLOGY LICENSING OPPORTUNITY: SignalGen
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Columbus, OH
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- S-195368
- Opportunity Type
- Special Notice
- Agency
- ENERGY, DEPARTMENT OF
- Sub-Agency
- ENERGY, DEPARTMENT OF
- Office
- TRIAD - DOE CONTRACTOR
- Posted Date
- Tuesday, September 22, 2026
- Response Deadline
- Monday, March 22, 2027
- PSC Code
- AN12
- Set-Aside
- No Set Aside
- Place of Performance
- Columbus, OH, 43201
- Status
- Active
Description
A platform that predicts the right signal peptide for a specific protein Many medicines, vaccines, and biotechnology products rely on proteins reaching the right cellular compartment or secretion outside a cell. Whether a protein gets there in enough quantities depends on its signal peptide or leader sequence. Scientists can identify many existing signal peptides, but predicting which one will work best for a specific protein remains difficult. SignalGen uses generative AI to predict the signal peptide most likely to guide a protein to the right location. To make that prediction, it considers the protein, where it needs to go, and the organism it comes from. This approach gives researchers a new way to improve protein expression for medicines, vaccines, and biotechnology products. Overview
Why This Opportunity Matters
ENERGY, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in Columbus, OH. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts